 | Cellectar Biosciences, Inc. | |||
| NCM : CLRB || Location: United States | ||||
$3.03-0.01 (-0.33%) |
0.81 M | 3.01 - 3.16 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.532 M |
| Feb. 29, 2024 | 2.008 M |
| Feb. 15, 2024 | 2.365 M |
| Jan. 31, 2024 | 1.885 M |
| Jan. 12, 2024 | 1.666 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.58 | -0.61 | -4.92% |
| 09/30/2023 | -0.54 | -0.83 | -55.00% |
| 06/30/2023 | -0.65 | -0.73 | -12.41% |
| 03/31/2023 | -0.88 | -0.76 | 14.11% |
| 12/31/2022 | -1.10 | -0.55 | 49.84% |
CLRB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 32.261M | Shares Float | 24.617M |
| Short Float | 2.532M | Market Cap | 97.75M |
| Institution ownership | 30.47% | Insider ownership | 3.570% |
| Earnings Date | 05/06/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.11 | Forward EPS | -2.83 |